MIAN, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.404
AS - Asia 11.670
EU - Europa 6.380
AF - Africa 1.781
SA - Sud America 1.778
Continente sconosciuto - Info sul continente non disponibili 324
OC - Oceania 182
Totale 42.519
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.019
SG - Singapore 3.171
CN - Cina 2.261
IT - Italia 2.087
VN - Vietnam 1.872
BR - Brasile 1.072
HK - Hong Kong 1.043
BD - Bangladesh 912
DE - Germania 454
CA - Canada 421
FR - Francia 400
SE - Svezia 382
FI - Finlandia 361
GB - Regno Unito 347
IN - India 310
NL - Olanda 279
RU - Federazione Russa 246
PL - Polonia 234
AR - Argentina 156
IQ - Iraq 152
BJ - Benin 148
JP - Giappone 145
KR - Corea 141
TR - Turchia 140
MX - Messico 127
UA - Ucraina 120
PK - Pakistan 117
CO - Colombia 106
ID - Indonesia 105
ZA - Sudafrica 105
IE - Irlanda 95
PH - Filippine 93
JM - Giamaica 84
SA - Arabia Saudita 84
ES - Italia 82
CR - Costa Rica 81
AT - Austria 79
MA - Marocco 78
VE - Venezuela 77
EC - Ecuador 72
MY - Malesia 70
UZ - Uzbekistan 69
TN - Tunisia 68
AE - Emirati Arabi Uniti 67
BE - Belgio 67
AU - Australia 66
CI - Costa d'Avorio 65
TH - Thailandia 65
RO - Romania 63
EG - Egitto 61
HN - Honduras 59
KE - Kenya 59
UY - Uruguay 57
RS - Serbia 56
AO - Angola 55
PR - Porto Rico 55
PY - Paraguay 55
HR - Croazia 53
HU - Ungheria 53
BG - Bulgaria 52
GR - Grecia 52
GT - Guatemala 52
JO - Giordania 52
AM - Armenia 51
LV - Lettonia 51
MK - Macedonia 51
AL - Albania 50
EE - Estonia 50
NI - Nicaragua 50
SI - Slovenia 50
CH - Svizzera 49
PA - Panama 49
SK - Slovacchia (Repubblica Slovacca) 49
SN - Senegal 49
AZ - Azerbaigian 48
CZ - Repubblica Ceca 48
PE - Perù 48
DK - Danimarca 47
NO - Norvegia 47
CL - Cile 46
CW - ???statistics.table.value.countryCode.CW??? 46
NP - Nepal 46
DZ - Algeria 45
KG - Kirghizistan 45
NZ - Nuova Zelanda 45
IL - Israele 44
IR - Iran 44
CY - Cipro 43
DO - Repubblica Dominicana 43
KZ - Kazakistan 43
MD - Moldavia 43
SO - Somalia 43
TT - Trinidad e Tobago 43
BB - Barbados 42
BO - Bolivia 42
BZ - Belize 42
GF - Guiana Francese 42
LA - Repubblica Popolare Democratica del Laos 42
PT - Portogallo 42
BW - Botswana 41
Totale 40.328
Salva come PNG Salva come JPEG
Città #
Ashburn 2.849
San Jose 1.975
Singapore 1.931
Fairfield 1.733
Woodbridge 943
Hong Kong 901
Chandler 733
Houston 726
Seattle 637
Cambridge 615
Ann Arbor 595
Wilmington 576
Ho Chi Minh City 533
Beijing 485
Los Angeles 473
Council Bluffs 439
Hanoi 427
Santa Clara 422
Boardman 318
New York 267
Milan 218
Jacksonville 213
Princeton 183
Padova 182
Hefei 179
Helsinki 179
Buffalo 173
San Diego 167
Lauterbourg 164
Dallas 153
Cotonou 146
Rome 141
Bytom 121
Chicago 119
Des Moines 114
Medford 113
São Paulo 111
Dong Ket 109
Da Nang 103
Seoul 100
London 94
Munich 91
Tokyo 88
The Dalles 84
Nanjing 82
Dublin 81
Orem 80
Guangzhou 77
Montreal 75
Phoenix 74
Warsaw 72
Naples 70
Baghdad 69
Toronto 68
Haiphong 67
Abidjan 64
Nuremberg 64
Roxbury 64
Amsterdam 63
Tashkent 61
San José 59
Columbus 57
Padua 55
Atlanta 54
Brooklyn 53
Johannesburg 50
Dakar 49
Kingston 48
Luanda 48
Managua 48
Nairobi 48
Panama City 48
Amman 47
Denver 47
Frankfurt am Main 47
Turku 47
Yerevan 46
Montevideo 45
Riga 45
Stockholm 45
Shanghai 44
Baku 43
Bologna 43
Vienna 42
Bishkek 41
San Francisco 41
Brasília 40
Changsha 39
Redondo Beach 39
Castries 38
Florence 38
Kampala 38
Vientiane 38
Bridgetown 37
Jinan 37
Willemstad 37
Chennai 36
Niamey 36
Andorra la Vella 35
Ulan Bator 35
Totale 23.817
Salva come PNG Salva come JPEG
Nome #
0C22 men2A da mutazione di ret C6009S. descrizione di una grande famiglia 622
L’elastosonografia come sostituto dell’esame citologico nei nodi soffici 502
The Hobnail variant of Papillary Thyroid Carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes 422
Differences in autoimmune thyroid diseases between females and males: the result of a complex interconnection of factors 412
PROGNOSTIC SIGNIFICANCE OF TERT PROMOTER AND BRAF MUTATIONS IN TIR-4 AND TIR-5 THYROID CYTOLOGY 404
Diagnostic tests for medullary thyroid carcinoma: an umbrella review 388
BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience. 382
Familial nonsyndromic pheochromocytoma. 380
Novel Prognostic Factors Associated with Cell Cycle Control in Sporadic Medullary Thyroid Cancer Patients 350
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC 346
Crude extract of Origanum vulgare L. induced cell death and suppressed MAPK and PI3/Akt signaling pathways in SW13 and H295R cell lines 344
Effects of Handroanthus impetiginosus (Mart. ex DC.) Mattos extract on inflammatory, immune, atherogenic profile and differentiation in THP-1 cell line 343
Overexpression of L-Type amino acid transporter 1 (LAT1) and 2 (LAT2): Novel markers of neuroendocrine tumors 321
BRAF analysis before surgery for papillary thyroid carcinoma: correlation with clinicopathological features and prognosis in a single-institution prospective experience 321
Impact of multidimensional assessment on anti-fracture treatment decisions in patients with fragility hip fractures within a Fracture Liaison Service 320
Prevalence, Tumorigenic Role, and Biochemical Implications of Rare BRAF Alterations. 319
The effects of iodine supplementation in pregnancy on iodine status, thyroglobulin levels and thyroid function parameters: Results from a randomized controlled clinical trial in a mild-to-moderate iodine deficiency area 319
Bone turnover markers, BMD and TBS after short-term, high-dose glucocorticoid therapy in patients with Graves’ orbitopathy: a small prospective pilot study 319
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up 311
Frequency and significance of Ras, Tert promoter, and Braf mutations in cytologically indeterminate thyroid nodules: A monocentric case series at a tertiary-level Endocrinology unit 309
Amiodarone-induced thyrotoxicosis: Differential diagnosis using 99mTc-SestaMIBI and Target-to-Background Ratio (TBR) 303
PTH: Redefining Reference Ranges in a Healthy Population-The Role of Interfering Factors and the Type of Laboratory Assay 297
Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling 296
Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells 292
BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma. 290
BRAF in primary and recurrent papillary thyroid cancers the relationship with (131) 1 and 2 [(18)F] fluoro-2-deoxy-D-glucose uptake ability. 289
Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment 287
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line 286
The role of the size in thyroid cancer risk stratification 286
Taking care of inpatients with fragility hip fractures: the hip-padua osteosarcopenia (Hip-POS) fracture liaison service model 285
Galectin-3 cytotest in thyroid follicular neoplasia: a prospective,monoinstitutional study 285
Biological effects of EF24, a curcumin derivative, alone or combined with mitotane in adrenocortical tumor cell lines 283
Iodine status from childhood to adulthood in females living in North-East Italy: Iodine deficiency is still an issue. 280
The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings 278
Efficacy of educational intervention to improve awareness of the importance of iodine, use of iodized salt, and dietary iodine intake in northeastern Italian schoolchildren 277
Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period 274
Anticancer Effects of Wild Mountain Mentha longifolia Extract in Adrenocortical Tumor Cell Models 272
Prophylactic and Early Thyroidectomy in RET Germline Mutation Carriers in Pediatric and Adult Population: Long-Term Outcomes of a Series of 63 Patients 268
A Novel Thyroid Hormone Receptor Beta Mutation (G357R) in a Family with Resistance to Thyroid Hormone Beta: Extending the Borders of the "Hot" Region in the THRB Gene 268
Women with Autoimmune Thyroiditis Taking Levothyroxine During Pregnancy: Is Iodine Supplementation Needed? 264
Mitogen-Activated Protein Kinase Pathway: Genetic Analysis of 95 Adrenocortical Tumors. 263
First proof of association between autoimmune polyglandular syndrome and multiple endocrine neoplasia in humans 263
EF24 (a curcumin analog) and ZSTK474 emphasizes the effect of cabozantinib in medullary thyroid cancer 261
Selenium Supplementation, Body Mass Composition, and Leptin Levels in Patients with Obesity on a Balanced Mildly Hypocaloric Diet: A Pilot Study 261
Iodine status in schoolchildren living in northeast italy:the importance of iodized-salt use and milk consumption. 259
Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications 259
Anti-Proliferative and Anti-Migratory Activity of Licorice Extract and Glycyrrhetinic Acid on Papillary Thyroid Cancer Cell Cultures 258
Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake 258
Functional Significance of the Novel H-RAS Gene Mutation M72I in a Patient with Medullary Thyroid Cancer. 258
Calcitonin measurement and immunoassay interference: A case report and literature review 257
Restricted intraindividual urinary iodine concentration variability in nonfasting subjects 253
Prognostic Impact of miR-224 and RAS Mutations in Medullary Thyroid Carcinoma 253
The PDCD4/miR-21 pathway in medullary thyroid carcinoma. 252
Combining Procalcitonin and Calcitonin for the Diagnosis of Medullary Thyroid Cancer: A Two‐Step Approach 250
Normal values for thyroid ultrasonography, goiter prevalence and urinary iodine concentration in schoolchildren of the Veneto Region, Italy 250
Autoimmune thyroiditis incidence in a large population-based study in northeastern Italy 249
First Evidence of Mineralocorticoid Receptor Gene and Protein Expression in Rat and Human Thyroid Tissues and Cell Cultures 248
Association of primary aldosteronism with chronic thyroiditis 248
BRAF V600E confers male sex disease-specific mortality risk in patients with papillary thyroid cancer 248
TSH-receptor autoantibodies in patients with chronic thyroiditis and hypothyroidism 246
Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience 246
Euthyroid hyperthyroxinemia: relevance of albumin and transthyretin genetic variations in a single centre experience 246
Programmed cell death 4 (PDCD4) as a novel prognostic marker for papillary thyroid carcinoma 245
Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma 245
Role of Lugol solution before total thyroidectomy for Graves’ disease: randomized clinical trial 241
Risk and Protective Factors of Postoperative and Persistent Hypoparathyroidism after Total Thyroidectomy in a Series of 1965 Patients 239
Calcitonin levels in autoimmune atrophic gastritis-related hypergastrinemia 239
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer. 237
Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario 237
The prognostic value of tumor multifocality in clinical outcomes of papillary thyroid cancer 233
The role of procalcitonin in the follow-up of medullary thyroid cancer 233
Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows 232
A Multiomodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients 231
INFLUENCE OF PHYSIOLOGICAL DIETARY SELENIUM SUPPLEMENTATION ON THE NATURAL COURSEOF AUTOIMMUNE THYROIDITIS 230
RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series 230
Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening 230
Tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary Thyroid Carcinoma 227
Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants 224
Circulating miR-146a predicts glucocorticoid response in thyroid eye disease 222
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. 221
microRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. 220
Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations 220
Can ultrasensitive thyroglobulin immunoassays avoid the need for ultrasound in thyroid cancer follow-up? 220
Biological activities of the aerial and undergound parts of Gymnadenia nigra Rchb.f. (syn. Nigritella nigra (L.) Rchb. f.) from the Italian Alps 219
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 218
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma 218
Adrenal crisis: incidence, clinical presentation and risk factors in patients with Addison’s disease 218
Crude extract of Origanum vulgare L. induced cell death and suppressed MAPK and PI3/Akt signaling pathways in SW13 and H295R cell lines 217
Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review. 216
BRAF nei carcinomi tiroidei primitivi e nelle loro recidive: correlazione con la capacità di concentrare lo iodio e il 18-FDG 216
MiR-375 and YAP1 expression profiling in medullary thyroid carcinoma and their correlation with clinical–pathological features and outcome 216
A Novel TSH Receptor Gene Variant Associated With Non-Autoimmune Hyperthyrotropinemia: a Case Report 215
Comparison Of The Diagnostic Accuracy Of Combined Elastosonography And Braf Analysis Versus Cytology And Ultrasonography For Thyroid Nodule Suspected Of Malignancy. 214
Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. 214
Unique Case of a Large Indolent Medullary Thyroid Carcinoma: Time to Reconsider the Medullary Thyroid Adenoma Entity? 212
Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience. 209
Iodine status in pregnancy: role of dietary habits and geographical origin 208
Sentinel lymph node mapping: current applications and future perspectives in thyroid carcinoma 207
Effects of selenium supplementation on the natural course of autoimmune thyroiditis: A short review. 206
Therapeutic Plasma Exchange for the Treatment of Hyperthyroidism: Approach to the Patient with Thyrotoxicosis or Antithyroid-Drugs Induced Agranulocytosis 204
Totale 27.163
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.461
article - articoli 112.342
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 967
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 230.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.595 0 0 0 167 166 129 138 218 144 56 172 405
2022/20231.546 314 200 14 204 216 216 17 85 168 23 69 20
2023/20241.106 41 106 158 91 101 106 121 63 61 56 106 96
2024/20254.374 35 242 247 200 499 182 233 370 405 159 710 1.092
2025/202622.107 975 1.746 2.637 3.189 1.751 998 3.127 1.737 2.151 1.274 1.411 1.111
2026/20274.343 1.273 1.232 1.000 838 0 0 0 0 0 0 0 0
Totale 42.519